BMC Psychiatry

Background: Self-harm is a frequent and challenging occurrence in adult inpatient psychiatric units. The use of restrictive practice to manage self-harm incidents continues to be widespread within mental health environments despite increasing national and organisational guidance to minimise its use. Aim: The aim of this project was to introduce and evaluate a continuous quality improvement programme to progressively reduce incidents of self-harm and the use of restrictive practice. The project was set in a female acute mental health inpatient unit. The project sought to embed improvements in an inpatient unit interventions, procedures, and culture and staff mindset, and move towards a sustained collaborative and positive therapeutic and communication-based approach. Methods: A retrospective service evaluation design was employed to assess differences in the number of incidents of self-harm, enhanced observation, seclusion, restraint and rapid tranquillisation in the period following the introduction of a continuous whole-systems multimodal interventional initiative in 2019. Pre- and post-initiation data were compared (2017/18 compared to 2019/2025) to evaluate improvement and whether this had been sustained. Data were analysed using descriptive statistics, including frequencies, percentages, and means. Results: Self-harm incidents reduced between 2017/18 and 2019, with a downward trend sustained between 2019 and 2025 (136 to 72 incidents respectively between 2019 and 2025; 47% reduction). A sustained reduction in the use of restrictive practice was shown in all domains pre- and post-initiation (2017/18 compared to 2025). Clinical implications: No one approach will successfully reduce self-harm and the use of restrictive practice. Approaches employed have to be multi-faceted, multi-interdisciplinary, collaborative, and blend together to deliver improvement. Sustained progress requires commitment to an iterative process of continuous collaboration, improvement and adaptation.

Borderline personality disorder (BPD) has traditionally been viewed as one of the most chronic psychiatric disorders. Although longitudinal studies have demonstrated promising rates of symptomatic remission, recovery and other clinical outcome measures often remain comparatively low. Qualitative research offers an important perspective on how individuals with BPD may extend a more representative view of improvement and change. We collected narratives from 41 participants with a self-reported diagnosis of BPD and analyzed them using thematic analysis. Its national, virtual recruitment approach enabled a relatively large qualitative sample diverse in gender identity, age, U.S. geographic region, treatment history, and current clinical severity, extending the range of perspectives represented in prior work. Three central themes were identified. The first, Differing attitudes toward language, reflected participantsexperiences of recovery language as paradoxically both validating and stigmatizing. While individual language preferences varied, participants generally converged on a sharedunderstanding of what recovery meant to them. The second, Recovery as a dynamic and relational process, described recovery as nonlinear, effortful, and closely tied to interpersonal experiences. The third, Crossroads and uneven change over time, highlighted the role of personal agency, critical decision points in seeking treatment, and the persistence of internal distress even as behavioral symptoms improve. Findings from this study both replicate and extend existing qualitative research by discussing how individuals with BPD understand recovery in ways that may not be captured by traditional clinical outcome measures. These results emphasize the importance of incorporating lived-experience perspectives when defining recovery and setting treatment goals.

Those leaving military service frequently present with complex psychosocial problems, but military veterans are often reluctant to engage with statutory healthcare provision. Specialist mental health services have recently been established in the UK to specifically support military veterans with their psychological and social wellbeing. We explored the treatment and support provided by the London branch of a military veterans mental health and wellbeing service (Op COURAGE) from the perspectives of the multidisciplinary service team and their partner organisations and collaborators. We conducted semi-structured interviews with multidisciplinary service staff and members of their partner organisations and external agencies. Qualitative data were analysed using framework analysis.?A total of 16 professionals participated in this study, comprising five service staff, eight collaborators and three partner agency participants. Five themes with subthemes were identified, including (1) blended networks, (2) staff inclusivity and sensitivity, (3) spectrum of psychosocial interventions and holistic support, (4) referral mechanisms, and (5) (in)visibility of the service and advertising. Our evaluation highlighted the advantages of a multidisciplinary team and collaborative partnerships to meet the psychosocial needs of veteran and their significant others. We have proposed that service improvement could include increasing advertisement about this specialist service, deepening knowledge about veterans among staff and further involving veterans and key stakeholders in service decisions.

Background: Autistic people experience substantially higher rates of mental health conditions and are overrepresented in mental health services. However, most interventions and service models have been developed for non-autistic people, and evidence is needed as to whether there are disparities in outcomes. This systematic review aimed to compare outcomes between autistic and non-autistic people receiving the same mental health interventions or services. Methods: We conducted a systematic review following PRISMA guidelines (PROSPERO: CRD420251021068). We searched academic databases (MEDLINE, Embase, PsycINFO, PubMed, CINAHL), a grey literature database (HMIC), a trial registry (ISRCTN), preprint servers (medRxiv and PsyArXiv), Google, and Google Scholar, to identify relevant papers published 01/01/1992-30/04/2026. We conducted backwards and forwards citation searching and contacted experts. Study quality was assessed using a modified Critical Appraisal Skills Programme Cohort Study Checklist and the Autism-Inclusive Research Assessment (AIRA). Data were synthesised narratively, with random effects meta-analyses where appropriate. Results: Thirty-nine studies were included, comprising 4787730 participants, assessing outcomes of psychological therapies (n = 17) and multi-component or service-level approaches (n = 22). Nearly half (46.2%) were UK-based, and under a quarter (23.1%) included people with intellectual disabilities. Ten studies (25.6%) were rated low quality, twenty-two (56.4%) medium quality, and seven (17.9%) high quality. AIRA ratings highlighted concerns about research inclusiveness for autistic people, including limited involvement of autistic people and lack of validated or adapted outcome measures. Findings varied by intervention: for some, multiple large, higher-quality studies showed less favourable outcomes for autistic people (e.g., less improvement in symptoms or functioning, or higher rates of restrictive practices or acute service use). For other interventions, comparable or mixed outcomes were found across studies, with interpretation often limited by small samples. Conclusions: Mental health treatment outcomes for autistic versus non-autistic people varied across interventions and outcome types. Where significant differences were observed, these usually showed poorer outcomes for autistic people, although they generally reflected smaller improvements rather than a lack of benefit. Action is needed to improve the accessibility and appropriateness of mental health care for autistic people, supported by more high-quality, co-produced research across a broader range of countries and service contexts.

While Artificial intelligence (AI) is increasingly being integrated into psychotherapy, little is known about how prospective patients evaluate different levels of AI involvement. Participants (n = 1,003) with depression evaluated vignettes describing psychotherapy options, from treatment delivered without AI integration (Human therapist) to treatments involving different degrees of AI integration (Assistive, Collaborative, Fully Autonomous AI). Participants consistently evaluated Human therapists more favorably, reporting a greater likelihood of seeking treatment, less hesitancy, and greater treatment acceptability. Economically, compared with a Human therapist, participants were willing to pay 31.6% less for therapists using Assistive or Collaborative AI and 57.2% less for Fully Autonomous AI. 18-19% of participants indicated that they would refuse treatment involving Assistive or Collaborative AI, compared with 31% for Fully Autonomous AI. Preference for Human over AI therapists was particularly pronounced at higher levels of therapist experience (doctoral/masters vs. peer/trainee). Overall, participants valued psychotherapy delivered by Human therapists more highly than AI integrated psychotherapy. These findings suggest that, despite increasing AI integration in mental health care, prospective patients continue to view psychotherapy as a distinctly human endeavor.

BackgroundPsychotic-like experiences (PLEs) have been shown to increase the risk for mental health problems in later life, especially psychosis. Following previously raised methodological concerns about the assessment of PLEs in adolescents, this study sought to differentiate subtypes of PLEs and to explore their trajectories. MethodsLongitudinally matched data of 671 German adolescents from three surveys over the time span of one year were analysed. Four trajectories were identified, including persisting, subsiding, and emerging highly indicative PLEs (HIPs), and non-highly indicative PLEs (non-HIPs), and longitudinally compared in terms of associated distress, psychopathology, and substance use. A differentiated never PLEs group was considered as a control. ResultsThe persisting HIPs group reported greater distress than the non-HIP group over time and was consistently associated with higher rates of internalising symptoms. The subsiding HIP group showed significant reductions in distress and internalising symptoms over time, but no significant changes regarding externalising symptoms and substance use. There was no difference in the extent of substance use between the groups. ConclusionsScreenings of PLEs should be mindful of different subtypes of PLEs that indicate a greater associated risk of poor mental health. PLE screening should not stop at whether PLEs are present but ask which ones.

Objective: Parent-adolescent disagreement in ratings of attention-deficit/hyperactivity disorder (ADHD) symptoms can complicate clinical assessment. This study examined parent - adolescent agreement in ADHD symptom ratings and characteristics associated with disagreement. Method: Participants were 1,008 parent-adolescent dyads recruited from a nationally stratified U.S. community sample. Adolescents were 12--18 years old (49.6% female) and along with their parents completed measures of ADHD and depressive symptoms. Agreement on Inattention (IN), Hyperactivity/Impulsivity (HI), and Total ADHD scores was examined. Item-level agreement was assessed using weighted kappa, Gwet 's AC2, percent agreement, and polychoric correlations. Associations between age, sex, and severity of ADHD and depression with levels of agreement were analyzed. Results: Agreement for ADHD factor and total symptom scores was moderate (intraclass correlations = 0.67--0.71), with moderate-to-strong rank-order correspondence. Adolescents reported slightly higher ADHD symptom levels than parents, although the mean difference was small. Item-level agreement was moderate to high (Gwet 's AC2 = 0.79--0.95). Several HI items demonstrated the kappa's paradox, with relatively low kappa values despite high Gwet's AC2 and percent agreement. Q-correlations revealed low agreement on relative strengths and weaknesses. Age and sex were not associated with disagreement and parent-reported ADHD severity and adolescent-reported depressive symptoms were associated with disagreement. Conclusions: Parent and adolescent ratings showed moderate agreement across boys and girls ages 12-- 18; however, disagreement related to relative strengths and weaknesses. Disagreement was associated with ADHD and depressive symptom severity. Findings suggest that ratings from parents and adolescents offer unique perspectives on the assessment of ADHD symptoms.

Background: Dissociative identity disorder (DID) is associated with frequent psychiatric comorbidity. Its complex and overlapping symptom profile can complicate recognition of both DID and co-occurring psychiatric conditions, contributing to diagnostic uncertainty. Evidence regarding psychiatric comorbidity is limited and prevalence estimates vary across studies. Aims: This meta-analysis aimed to examine the prevalence of psychiatric comorbidities in DID and factors associated with variation in prevalence estimates. Methods: Eligible studies were identified through PubMed, Scopus, Embase, PsycINFO, and MEDLINE from 1980 to 25 April 2026 (PROSPERO, no. CRD420261335819). Studies reporting psychiatric comorbidity in adults with DID were independently screened by two reviewers. Risk of bias was assessed. Random-effects meta-analyses using logit-transformed prevalence estimates were conducted. Meta-regressions examined moderators, whilst influence and sensitivity analyses assessed robustness. Certainty was evaluated using the GRADE approach. Results: Twenty-four studies (N = 858) contributed to the meta-analysis across 23 psychiatric comorbidities. Among individuals with DID, posttraumatic stress disorder had the highest pooled prevalence (87.44%, 95% CI 71.79-94.96), followed by major depressive disorder (62.64%, 95% CI 33.45-84.84), and borderline personality disorder (47.05%, 95% CI 34.21-60.32). Substantial heterogeneity was noted across most estimates. Meta-regressions identified significant associations with participant characteristics, recruitment, study quality, and diagnostic method. Risk of bias and certainty of evidence were heterogenous. Conclusions: Psychiatric comorbidity in DID is substantial and spans multiple diagnostic categories, although considerable heterogeneity and methodological variation limit confidence in prevalence estimates. Standardised diagnostic assessment, more representative sampling, and longitudinal research are needed to clarify the extent and clinical significance of comorbidity in DID.

People from UK South Asian communities experience barriers to accessing dementia care. Evidence suggests that evidence-based psychosocial dementia interventions can be successfully adapted for different cultural contexts, but further evidence is needed on how adaptations are developed and refined in practice. We aimed to adapt GRACE-family (Goal diRected, Accessible and Evidence-based Care), an evidence-based, manualised post-diagnostic dementia intervention, comprising 4-8 sessions for family carers and where possible, people with dementia, for Bengali-speaking communities. In a theory-informed process, a co-adaptation group encompassing lived, academic and clinical/professional experience developed consensus regarding which intervention functions were core. They then explored how adaptation might, while retaining these, account for cultural and linguistic contexts, informed by focus groups with memory service and Bengali community organisation staff (n=14). We developed a prototype adaptation, then piloted it with four Bangladeshi families supporting a person with dementia. Post-intervention, participants were asked about goal attainment, intervention acceptability, and qualitatively interviewed. Pilot data and a focus group with Sylheti-speaking family carers informed further refinements (n=6). Across data sources, two themes informed adaptation: (1) stigma, trust and community networks shaped access to dementia support; (2) flexible delivery was needed to respond to diverse language, communication and cultural needs. 3/4 pilot families completed the prototype intervention, which was in English as initial consultation cautioned against developing a written manual in a predominantly spoken language. Participants reported improvement on 7/8 personalised goals set, and all considered the intervention acceptable. Pilot delivery identified challenges using English-language materials during interpreter-mediated sessions. Iterative refinements added standard Bengali materials and spoken Sylheti audiovisual resources to broaden delivery options and facilitator training for culturally responsive and interpreter-mediated delivery. Our co-adaptation approach enabled stakeholders to advise from different, including experiential perspectives. It may inform future approaches to cultural and linguistically adaptations of psychological interventions for minoritised communities.

BackgroundAtypical antipsychotics (AAPs) are increasingly prescribed for paediatric patients with autism spectrum disorder (ASD). However, pharmacovigilance data from Saudi Arabia remain scarce. The aim of this study is to detect and characterise signals associated with AAPs and assess gender- and age-related ADR reporting patterns. MethodsA retrospective cross-sectional study with disproportionality analysis was conducted on paediatric patients (0-19 years) using the Saudi Food and Drug Authority (SFDA) database (2021-2024). Disproportionality analyses were performed using the reporting odds ratio (ROR), proportional reporting ratio (PRR), and Bayesian confidence propagation neural network (BCPNN). Age and gender were assessed using odds ratios (ORs), with Firth penalized logistic regression to confirm associations. ResultsOverall, 701 ADR reports were analysed. Most involved males (59.91%) and children aged 0-9 years (82.88%). Olanzapine had the highest proportion of serious reports (44.44%). At the system organ class (SOC) level, signals included nervous system disorders with risperidone (ROR 32.61 [16.62-64.00]; PRR 3.49 [2.22-5.47]; IC025 0.08); cardiac and general disorders with quetiapine; haematological, metabolic, and psychiatric disorders with olanzapine; and gastrointestinal disorders with aripiprazole. Gender-adjusted analyses indicated significant variation in selected ADR signals across age groups, while no significant differences were observed by gender. ConclusionsThis study highlights disproportionality signals associated with AAP use in paediatric patients. Age-related ADR variation supports consideration of age-specific ADR monitoring within current paediatric recommendations. While these findings do not establish causality, they generate hypotheses for further evaluation. Regional pharmacovigilance may complement international paediatric safety monitoring frameworks.

Abstract Background: The 52-item Ontario Child Health Study Emotional Behavioural Scales (OCHS-EBS) has demonstrated reliability and validity evidence in Canadian population-based samples. This study evaluated an adapted item set of the Ontario Child Health Study Emotional Behavioural Scales (OCHS-EBS-A) intended to measure selected mental disorder symptoms while reducing respondent burden in population-based research. Methods: A prespecified candidate set of 21 items from selected OCHS-EBS disorder scales assessed depression (4 items), generalized anxiety (4 items), oppositional behaviour (6 items), and attention-deficit/hyperactivity (7 items). The 2023 Longitudinal Canadian Health Survey on Children and Youth (L-CHSCY; ages 5-21 years; n= 22,740) provided calibration and internal-validation samples. The Ontario Provincial Assessment and Tracking of Child and Family Health Study (ONPATH; Wave 5: n=719 parent and n=116 youth respondents) provided an independent sample for further evaluation. Analyses examined factorial validity, internal consistency reliability, convergent and discriminant validity, and measurement invariance across sex assigned at birth within age/informant groups. Findings: The analyses supported a refined 20-item OCHS-EBS-A with three correlated factors representing internalizing, oppositional behaviour, and inattention/hyperactivity symptoms. Prespecified criteria for internal consistency reliability and convergent and discriminant validity were met within the reported L-CHSCY age/informant groups. Measurement invariance across sex assigned at birth was supported in the L-CHSCY groups and for children and parents in and youth-reported internalizing symptoms in ONPATH. However, not for ONPATH youth-reported oppositional behaviour symptoms. Interpretation: Results from these population-based samples provide factorial-validity, internal-consistency, and convergent- and discriminant-validity evidence for scores from the 20-item OCHS-EBS-A among children, youth, and emerging adults aged 5-21 years.

Child maltreatment (CM) is a global phenomenon, yet its prevalence, acceptability, and psychosocial consequences vary across cultures. This study examined self-reported CM, its perceived acceptability, and associations with psychosocial outcomes among 1,617 adults (Mage = 25.21, SD = 6.74) across 13 countries and regions. Participants completed an online survey assessing physical neglect, physical abuse, emotional maltreatment, sexual abuse, and witnessing domestic violence, alongside perceived acceptability, post-traumatic growth, resilience, perceived social support, post-traumatic symptoms, and psychological distress. Country/region differences were tested via mixed-effects; whether CM-outcome associations varied by country/region was tested via fixed-effects interaction models. Significant cross-country/region variability emerged for most CM subtypes, especially for emotional maltreatment. Witnessing domestic violence rates did not differ significantly, though its acceptability still varied significantly, as did all other types. Greater CM exposure was linked to poorer mental health for several subtypes and to greater acceptability of maltreatment, raising concerns about intergenerational normalisation. CM-outcome associations were largely consistent across countries/regions, with only isolated, exploratory exceptions. Findings show that while CM's adverse psychosocial impact shows little cross-national variation, its prevalence and normative framing are culturally shaped, underscoring the need for culturally sensitive assessment and intervention.

Autistic adults face considerable challenges in receiving adequate support, from both paid/formal (such as from disability services) and unpaid/informal (for example, from friends and family) sources. Having adequate support can lead to better health and well-being outcomes. However, most instruments designed to assess adequacy of support were not made specifically for/with autistic adults. This paper presents a psychometric validation of the AASPIRE Adequacy of Supports and Information Scale (AASIS), a community-informed adaptation of a previously developed instrument (the Quality of Care and Support scale; Lucas-Carrasco et al., 2011), designed to be relevant and accessible to autistic adults. We also used the AASIS to explore correlates of perceptions of support in a sample of 798 autistic adults. Our confirmatory factor analysis supported a two factor structure for the AASIS (factor one: Supports; factor two: Information). Further testing confirmed the instrument was invariant across several groups, including race/ethnicity, gender, intellectual disability, communication fluency, and self versus proxy-report. Regression analyses suggested that the way in which participants joined the study (i.e., through community advertisements or via established healthcare/disability services) impacted whether they viewed their support as adequate. Additionally, a higher number of adverse childhood events and greater experience of discrimination were related to worse perceptions of support adequacy across both factors. Our findings support the preliminary validity of the AASIS across a variety of autistic people, though further testing is warranted. Findings also point to the importance of addressing the needs of autistic people who are minoritized and/or who have complex trauma histories.

Background Psychiatric diagnoses and psychotropic medication use among children, adolescents, and young adults have increased in high-income countries, with concerns about geographic variation. We described national trends and geographic variation in Denmark from 2010 to 2025 and developed an interactive online tool to explore these patterns. Methods We conducted a nationwide, descriptive, repeated cross-sectional register-based study of all Danish residents aged 0-24 years in 2010-2025 (n=2,930,744), using the Danish National Patient Registry and the Danish National Prescription Registry. We estimated annual incidence, prevalence, and, for selected diagnoses, lifetime prevalence, by age and sex, and age- and sex-standardised rates across regions, health councils, and municipalities. We assessed geographic variation using deviations from national means, coefficients of variation, Gini coefficients, and funnel plots. Findings Psychiatric diagnoses and psychotropic medication use increased from 2010 to 2025. The annual prevalence of attention-deficit hyperactivity disorder (ADHD) increased from 0.41 to 2.3 per 100 individuals, autism spectrum disorders from 0.20 to 1.2, and melatonin use from 0.14 to 3.0. ADHD and autism spectrum disorders were more prevalent among boys and anxiety disorders among girls. Sertraline use was also more prevalent among girls. Geographic variation was observed across diagnoses and psychotropic medications at regional, health council, and municipal levels. For example, lifetime prevalence of autism ranged from 1.3 to 5.9 per 100 across municipalities, and in 2025 regional coefficients of variation ranged from 0.11 (sertraline) to 0.41 (atomoxetine). Results can be explored in the interactive online tool (https://bupstat.sdu.dk/?lang=en). Interpretation Psychiatric diagnoses and psychotropic medication use increased among Danish children, adolescents, and young adults, with marked geographic variation. Descriptive data cannot establish the causes of this variation, but the findings identify areas for further review and support continued monitoring. Funding Best for Us project (www.bedstforos.dk), funded by the Novo Nordisk Foundation (NNF24SA0093635) and the Obel Family Foundation (69348).

Importance. Anorexia nervosa (AN) is a severe metabo-psychiatric disorder with heterogeneous outcomes and elevated mortality. Characterizing severity trajectories may improve early risk stratification and targeted intervention. Objective. To identify AN severity trajectories using a register-based severity index (AN-RSI) and examine their associations with polygenic scores (PGS), preceding (prior to AN diagnosis) as well as subsequent (5 years post AN diagnosis) psychiatric and somatic disorders. Design. Population-based cohort study. Setting. Nationwide study in Denmark. Participants. Individuals born between 1969 and 2013 with diagnosed AN (N = 9,534 individuals). Genetic data were available in a subsample comprising 5,126 individuals. Exposures. Forty-one PGS indexing traits relevant to AN, and psychiatric and somatic disorders prior to AN diagnosis. Main Outcomes and Measures. The main outcomes of interest were the AN-RSI trajectories and psychiatric and somatic disorders 5 years post AN diagnosis. Results. Three trajectories were identified: "low and stable" (32.6%), "medium and stable" (53.5%), and "high increasing" (14.0%). The "low and stable" group was used as the comparison group for all analyses. Each 1 standard deviation (SD) increase in AN PGS corresponded with 13% greater odds of following the "high increasing" trajectory. Increases in BMI and attention-deficit/hyperactivity disorder PGS corresponded with 15% and 14% lower odds of following the "high increasing" trajectory, respectively. No preceding psychiatric or somatic disorders were significantly associated with trajectory assignment. In contrast, psychiatric and somatic disorders were more likely to occur subsequent to an AN diagnosis in those in the "high increasing" trajectory with odds ratios (OR) ranging between 1.73 and 3.81 for psychiatric disorders and between 1.61 and 5.38 for somatic disorders with a notable exception of obesity which showed a lower OR of 0.27. Conclusions and Relevance. Our findings hold significant clinical relevance by demonstrating that individuals with AN follow distinct severity trajectories that have different genetic risk as measured by PGS and clear differences in post-diagnosis morbidity patterns but no discernable differences in pre-diagnosis psychiatric or somatic morbidity. As the eating disorders genetics field progresses, incorporating PGS into comprehensive assessments at first presentation may aid in early identification, personalized intervention, and resource allocation for individuals at higher risk of developing a severe illness trajectory.

Abstract Background There is limited evidence to demonstrate the impact of training community mental health workers beyond knowledge acquisition. This study evaluated the training, workforce performance, and system-level outcomes of the Hamdard Force, a community mental health intervention, implemented in two districts of Khyber Pakhtunkhwa, Pakistan, as part of a multi-tiered, digital MHPSS service over 8 months. Methods We followed a multi-level evidence approach, guided by the New World Kirkpatrick Model, using a mixed-methods design that combined quantitative and qualitative indicators. We assessed participants' reactions, learning, behavioral outcomes, system-level outcomes of the intervention, and conducted Focus Group Discussions to identify contextual factors that influenced implementation. Results At Tier 1, a total of 403 community workers were trained, who reported satisfaction with the training content and relevance, and demonstrated significant improvement in knowledge post-training. Less than half of the trained workforce remained active in the field and referred people with mental healthcare needs under supervision. A total of 855 people were triaged by clinical psychologists at Tier 2 of the service model, and 549 cases met the criteria of being valid. The results of detailed clinical assessment and management demonstrated encouraging outcomes regarding the effectiveness of the intervention, both at the individual case and at the system-level. The Focus Group Discussions revealed the process of supervision, organizational support and digital tools of learning were significant drivers of the intervention. Challenges with internet connectivity, limited digital literacy, and persistent mental health stigma were identified as implementation barriers. Conclusion Overall, the integrated findings suggest that the intervention helped to build the capacity of the workforce, facilitated their performance through supervision, provided services through a task-sharing approach and strengthened referral pathways. These findings underscore the importance of implementation-focused evaluations for scaling up community mental healthcare in low-and middle-income countries.

Background: People with severe mental illness (SMI) report poorer oral health outcomes than the general population, are less likely to attend regular dental check-ups, and may require additional support to visit a dentist. Our previous research showed that interventions tailored to their needs and support from the mental health care system are needed to improve oral health outcomes in people with SMI. Although there is some provision of urgent dental care for people with SMI, there are currently limited available interventions that integrate dental and mental health care and provide dental support in a mental healthcare setting. To address this gap, the aims of the SMILE project are to 1) co-develop and 2) test the feasibility and acceptability of an oral health intervention for people with SMI, delivered by mental health professionals in secondary community mental health care settings. This paper describes the protocol for the feasibility and acceptability testing of the SMILE intervention. Methods: This is a single-arm, non-randomised feasibility trial assessing the feasibility and acceptability of an intervention to support the oral health of mental healthcare service users with SMI. The intervention was co-produced with service users, carers, mental health and dental health professionals, and includes advice on maintaining good oral hygiene and lifestyle habits to maintain good oral health. The main aim of the study is to assess the feasibility and acceptability of delivering the intervention, using quantitative data collected at baseline, three and six-month follow-up, and qualitative interviews with participants and mental health staff involved in delivering the intervention. Results: The study results will determine whether the intervention can be successfully delivered in secondary community mental health care settings and inform the most appropriate primary and secondary outcomes for a future trial. Conclusion: The findings of this study will inform the feasibility of progression to the pilot stage of a randomised controlled trial to assess the clinical and cost effectiveness of delivering an oral health intervention in a mental healthcare setting.

Objective: To provide national norms, percentiles, and results of factor analyses for the ADHD symptoms and performance items on the parent-report and self-report versions of the Vanderbilt Assessment Scale (VAS) for youth ages 6 to 17. We hypothesized that symptom items would demonstrate separate inattention and hyperactivity/impulsivity factors, performance items would demonstrate interpretable latent dimensions, measurement invariance would be supported across age and sex, and symptom ratings would vary systematically by age and sex. Method: In a nationally stratified survey conducted in July 2025-March 2026, 2,230 parents of youth aged 6-17 years and 996 adolescents aged 12-17 years completed Vanderbilt Assessment Scale items. Both versions asked about the frequency of 18 ADHD symptoms and performance in 8 domains. To evaluate the psychometric properties and age-related normative curves of the VAS across parent- and youth-report forms, we conducted exploratory factor analysis, confirmatory factor analysis, and measurement invariance testing. We also generated age and sex-specific norms. Results: Factor analyses produced the expected two symptom factors and two performance factors. Developmental and sex-specific patterns of ratings of inattention and hyperactivity/impulsivity symptoms indicated that after increasing slightly during the preadolescent years, parent ratings of inattention symptoms declined and remained stable. In contrast, ratings of hyperactivity/impulsivity declined steadily with age. Normative data were generated using GAMLSS estimated centiles from fitted probability distributions. Conclusions: This study provides norms for the parent-report and adolescent self-report VAS. Findings underscore the importance of using sex- and age-based norms to better inform estimates of severity and diagnostic decision making.

Objective: To evaluate the psychometric properties, factor structure, validity, and age- and sex-specific norms of the 21- and 10-item parent-report Child Mania Rating Scale (CMRS-P) in a nationally representative U.S. sample of youth aged 6-18 years. Method: Parents of 2,229 youth aged 6-18 years [weighted M(SD)=12.0(3.3) years; 45.9% female] completed the CMRS-P and related measures between July 2025 and March 2026. Data were weighted to represent U.S. demographics. A clinical comparison sample included parents of 522 youth seeking outpatient mental health services. Complete-case analyses evaluated reliability, factor structure, item response theory, measurement equivalence, retest stability, and convergent and discriminant validity. GAMLSS estimated age- and sex-specific norms. Results: Weighted mean scores were 8.5(SD=9.0) for CMRS-P-21 and 4.0(4.3) for CMRS-P-10. Internal consistency was high ({omega}=.97/.93), and forms correlated .95. A general severity factor explained most reliable variance ({omega}H=.94). Three items differed in response thresholds across samples, with an average impact below one point on expected total scores. Both forms correlated strongly with attention problems, suicidality, depression, externalizing symptoms, and emotion dysregulation (r=.51-.63 for CMRS-P-21) and negligibly with pubertal status. Reliable-change thresholds were 14.5 (CMRS-P-21) and 6.8 (CMRS-P-10) points. Weighted GAMLSS CMRS-P-21 95th percentiles declined with age in males (30-23) and increased in females (22-30), with wide bootstrap intervals at age extremes; the female trend was not replicated without weights. Conclusions: Findings support both CMRS-P forms for assessing youth manic symptoms. The first nationally representative U.S. norms provide age- and sex-adjusted benchmarks for interpreting scores and informing further clinical assessment.

Objective: The Genetic Risk for Serious Mental Illness and Development ("Paisa Kids") Study is establishing a longitudinal cohort of 3,000 youth enriched transdiagnostically for risk for serious mental illnesses (SMI; i.e., schizophrenia, bipolar disorder, and severe depression) from the Paisa region of Colombia. Its objective is to clarify the early clinical, neurobehavioral, genetic, and environmental profiles associated with later SMI and distinguish transdiagnostic from disorder-specific pathways. This paper describes the study infrastructure, recruitment streams, and baseline assessment battery, and characterizes the first two-thirds of the cohort. Method: Youth aged 6-15 years are being recruited. Youth recruited for high SMI risk either have a first or second degree adult relative with a SMI diagnosis or a psychiatric diagnosis themselves identified through electronic medical records (EMRs) associated with later SMI. Lower-risk youth have a relative without a SMI diagnosis. Baseline measures include psychiatric and developmental history, neurobehavioral functioning, environmental exposures, and genome-wide genotyping. Psychiatric EMRs provide longitudinal follow-up. Results: Among 2,384 participants enrolled thus far (mean age=11.2 years, 45.0% female), 2,211 were recruited for high SMI-risk and 173 for lower SMI-risk. Overall, 73.2% met criteria for a history of one or more psychiatric disorders. Logistic regression comparing rates of diagnoses and ACEs between recruitment streams showed elevated rates of depressive and anxiety disorders, attention-deficit/hyperactivity disorder, oppositional defiant disorder, and several ACEs among high versus lower SMI-risk youth. Conclusion: Integrating multidomain phenotyping, genomic data, and longitudinal EMR follow-up, the Paisa Kids cohort provides a unique resource for investigating pathways of risk and resilience to SMI.